معرفی
Martin Di Grandi serves as Associate Professor of Chemistry at Fordham University with dual appointments at both the Lincoln Center (808C) and Rose Hill (JMH 538) campuses. His research program bridges synthetic organic chemistry with therapeutic applications, focusing on novel methodologies and biologically relevant molecular systems.
Education
- Ph.D., March 1990, New York University
- B.Sc., May 1984, Fordham University
His research demonstrates exceptional breadth across three interconnected domains: antiviral development targeting herpesviruses through thiourea-based portal protein inhibitors, natural product synthesis exemplified by tetrahydroisoquinoline methodologies for pancratistatin core construction, and fundamental reaction mechanisms including diastereoselective reductions of α-hydroxyketones. This work consistently emphasizes therapeutic relevance while advancing synthetic technique.
Analysis of his 2009-2019 publications reveals a strategic evolution from target-specific inhibitor design (B-Raf, HIV RNase H) toward broader methodological contributions in cyclization chemistry and sustainable synthesis. The consistent thread is molecular innovation directed at biological challenges, particularly in oncology and virology, with increasing emphasis on mechanistic understanding and educational applications.
No information regarding scientific awards is provided in the source material. His patent portfolio indicates significant translational impact, though specific advising relationships and grant funding details remain undocumented in the available text.
